← Back to Clinical Trials
Recruiting NCT06343844

NCT06343844 Disparities in Myocardial Infarction Remodeling According to Gender

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06343844
Status Recruiting
Phase
Sponsor University Hospital, Angers
Condition Myocardial Infarction
Study Type INTERVENTIONAL
Enrollment 1,650 participants
Start Date 2024-07-15
Primary Completion 2039-11-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
cardiac imaging to assess left ventricular volumes and function

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,650 participants in total. It began in 2024-07-15 with a primary completion date of 2039-11-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Following myocardial infarction, female individuals demonstrate a poorer prognosis, characterized by elevated rates of mortality and heart failure. A primary hypothesis suggests unfavorable cardiac remodeling in women. This remodeling, defined as alterations in cardiac size and shape post-infarction, necessitates repeated non-invasive imaging for study.

Eligibility Criteria

Inclusion Criteria: * Age \> 18 years * First myocardial infarction with ST-segment elevation during the hospital phase * Coronary angiography performed within 72 hours of the infarction * Inclusion in the RIMA registry * Patient affiliated or beneficiary of a social security scheme; Signature of informed consent Exclusion Criteria: * Patients already enrolled in the study * Poor understanding of the French language * Pregnant, breastfeeding, or postpartum women * Individuals deprived of liberty by judicial or administrative decision; Individuals receiving psychiatric care under coercion * Individuals subject to a legal protection measure; Individuals incapable of giving consent

Contact & Investigator

Central Contact

LOIC BIERE, PHD

✉ LoBiere@chu-angers.fr

📞 02 41 35 36 37

Frequently Asked Questions

Who can join the NCT06343844 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06343844 currently recruiting?

Yes, NCT06343844 is actively recruiting participants. Contact the research team at LoBiere@chu-angers.fr for enrollment information.

Where is the NCT06343844 trial being conducted?

This trial is being conducted at Angers, France.

Who is sponsoring the NCT06343844 clinical trial?

NCT06343844 is sponsored by University Hospital, Angers. The trial plans to enroll 1,650 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology